Luigi Mangione admitted in a Manhattan federal courtroom Friday that he shot and killed UnitedHealthcare CEO Brian Thompson, a guilty plea that could now upend the separate state murder case against him.
The 28-year-old defendant, hands uncuffed behind his back and ankles shackled, stood in a beige prison jumpsuit and read from a written letter before U.S. District Judge Margaret Garnett. His voice was solemn, close to choking up, as he delivered the words that ended months of legal maneuvering.
Mangione pleaded guilty to two federal counts, interstate stalking resulting in death and stalking through use of interstate facilities resulting in death, charges that carry a maximum sentence of life in prison. The plea spares him a federal trial that had been set to begin in January, but it opens a new legal front: his defense team plans to argue that a separate New York state murder prosecution would amount to double jeopardy.
In his written statement, Mangione laid out the mechanics of the killing in plain, declarative language. The New York Post reported that Mangione told the court:
"I shot Mr. Thompson in Manhattan and he died."
He went further, describing his preparation in detail that left little ambiguity about premeditation.
"Before traveling to New York, I used a 3-D printer to make a gun. I equipped the gun with a silencer and a magazine."
Federal prosecutors say Mangione posed as an investor at a firm managing $150 million in assets, emailing UnitedHealthcare leadership to obtain details about the company's 2024 annual investor conference in New York City. That deception gave him the time and location he needed. On the morning of December 4, 2024, Thompson, a 50-year-old father of two, was shot on a Midtown Manhattan sidewalk outside the conference venue. He died from his wounds.
Bullet casings recovered at the scene bore the words "delay" and "deny" etched into them, language that echoed common criticisms of insurance industry claims practices. A five-day manhunt followed before police apprehended Mangione at a McDonald's in Altoona, Pennsylvania. Key evidence recovered from his belongings included the 3-D-printed pistol matching the weapon used in the shooting and a notebook describing his intent to kill an insurance executive.
Federal prosecutors have pointed to a written document attributed to Mangione, which they describe as a manifesto, as evidence of his motive. They say it stated his goal was to "rebel against the deadly, greed-fueled health insurance cartel" and to make a violent political statement. Mangione allegedly wrote that other high-level insurance executives were fair game because the industry "literally extracts human life force for money."
In court Friday, AP News reported that Mangione framed his actions as born from personal suffering, stating he acted "after years of enduring severe pain from a broken back and navigating the obstacles of the health insurance system." His written speech detailed grudges accumulated over years of chronic back pain.
None of that excuses the killing of a man who was walking to a work conference. Brian Thompson was not a policy abstraction. He was a husband and a father. His widow sat in the second row of the courtroom Friday, crying silently. His other relatives drew glares at Mangione as he walked in. They eyed him as he took his place before the judge.
The cultural response to the killing has been disturbing in its own right. After Mangione entered his plea, an unidentified man rode past the courthouse screaming, "America loves Luigi!" That a segment of the public has treated an admitted killer as a folk hero, part of a broader pattern of online assassination culture, says more about the country's civic rot than it does about the health insurance industry.
Defense attorney Karen Agnifilo told Judge Garnett simply:
"Mr. Mangione is prepared to plead guilty to the indictment at this time."
The judge then walked Mangione through a series of questions about the legal specifics of his plea. He responded "yes" to each. When Garnett told him the maximum sentence he faced was life in prison, Mangione nodded slightly. The judge also warned that any sentence in his pending state case could run consecutively, meaning time served in one case would not count toward the other.
A senior Department of Justice source confirmed to Fox News that no formal plea deal was in place. Mangione chose to plead guilty in open court on his own initiative. Federal prosecutors still intend to seek the maximum sentence of life without parole, though the final decision rests with the judge. His federal sentencing hearing is scheduled for December 18.
The guilty plea was not just an admission of guilt. It was a legal chess move. Agnifilo confirmed after the hearing that the defense will file a motion in state court arguing that prosecuting Mangione for the same conduct in New York would violate double jeopardy protections.
The argument has real teeth in New York. Former Southern District of New York prosecutor Andrew C. McCarthy wrote in National Review that New York, unlike most other states, allows a federal prosecution to nullify the state's authority to prosecute crimes arising from the same conduct. If the defense prevails, Mangione would face only the federal sentence, and would serve his time in federal prison, where conditions are generally better than in state facilities.
Retired NYPD inspector Paul Mauro, a Fox News contributor, laid out the strategic logic: "First of all, he gets to serve his time in federal prison, where conditions are better, and he is hoping that the New York state double jeopardy law will knock out the state case now and all he ever has is the federal case." Chicago criminal defense attorney Donna Rotunno added that defendants with no prior criminal history and an education rarely receive maximum sentences.
Mangione himself has been blunt about his view. In a February court appearance, he told a judge: "It's the same trial twice. One plus one is two. Double jeopardy by any commonsense definition." The surprise federal hearing that preceded the plea had already fueled speculation that this maneuver was coming.
State prosecutors are not conceding. Prosecutor Seidemann said any guilty pleas "must account for the seriousness of defendant's offenses, the loss of an innocent life, the impact of those crimes on the victim's family." Jury selection for the state murder trial remains scheduled for September 8. Mangione still faces state charges of second-degree murder, criminal possession of a forged instrument, and multiple counts of criminal possession of a weapon.
The legal landscape heading into the state trial has been shaped by a series of pretrial rulings. A judge barred some backpack evidence from the state trial but allowed the ghost gun and journal to stand, meaning the most damning physical evidence will likely confront any state jury that hears the case. Eighty-six news organizations have been approved to cover the proceedings, a sign of the extraordinary public attention the trial commands.
The defense has also pushed for cameras in the courtroom, a move some legal observers have interpreted as an attempt to use public sympathy to influence jurors. Whether any of that matters depends on whether the double jeopardy motion succeeds. If it does, the state case dies before a single juror is seated.
The Maryland prep school alum who had been expected to plead guilty did exactly that. He stood in a federal courtroom, read from a letter, and told a judge he manufactured a weapon and used it to end a man's life. Whatever grievances he carried about the health insurance system, he chose to resolve them not with a lawsuit, not with a public campaign, not with a vote, but with a bullet on a Manhattan sidewalk.
A civilized country does not celebrate that. It punishes it.
